Combined clinical trial results of a HER2/neu (E75) vaccine for the prevention of recurrence in high-risk breast cancer patients: U.S. Military Cancer Institute Clinical Trials Group Study I-01 and I-02. (Q40017255)
Jump to navigation
Jump to search
scientific article published on February 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Combined clinical trial results of a HER2/neu (E75) vaccine for the prevention of recurrence in high-risk breast cancer patients: U.S. Military Cancer Institute Clinical Trials Group Study I-01 and I-02. |
scientific article published on February 2008 |
Statements
1 reference
Combined clinical trial results of a HER2/neu (E75) vaccine for the prevention of recurrence in high-risk breast cancer patients: U.S. Military Cancer Institute Clinical Trials Group Study I-01 and I-02. (English)
1 reference
George E Peoples
1 reference
Jarrod P Holmes
1 reference
Matthew T Hueman
1 reference
Elizabeth A Mittendorf
1 reference
Asna Amin
1 reference
Steven Khoo
1 reference
Zia A Dehqanzada
1 reference
Jennifer M Gurney
1 reference
Michael M Woll
1 reference
Gayle B Ryan
1 reference
Catherine E Storrer
1 reference
Dianna Craig
1 reference
Constantin G Ioannides
1 reference
Sathibalan Ponniah
1 reference
1 February 2008
1 reference
1 reference
Identifiers
1 reference